Normal pregnancy is supported by increased levels of progesterone (P4), which is secreted from ovarian luteal cells via enzymatic steps catalyzed by P450scc (CYP11A1) and HSD3B. The development and maintenance of corpora lutea during pregnancy, however, are less well understood. Here we used Cyp11a1 transgenic mice to delineate the steps of luteal cell differentiation during pregnancy. Cyp11a1 in a bacterial artificial chromosome was injected into mouse embryos to generate transgenic mice with transgene expression that recapitulated endogenous Cyp11a1 expression. Cyp11a1 transgenic females displayed reduced pregnancy rate, impaired implantation and placentation, and decreased litter size in utero, although they produced comparable numbers of blastocysts. The differentiation of transgenic luteal cells was delayed during early pregnancy as shown by the delayed activation of genes involved in steroidogenesis and cholesterol availability. Luteal cell mitochondria were elongated, and their numbers were reduced, with morphology and numbers similar to those observed in granulosa cells. Transgenic luteal cells accumulated lipid droplets and secreted less progesterone during early pregnancy. The progesterone level returned to normal on Gestation Day 9 but was not properly withdrawn at term, leading to delayed stillbirth. P4 supplementation rescued the implantation rates but not the ovarian defects. Thus, overexpression of Cyp11a1 disrupts normal development of the corpus luteum, leading to progesterone insufficiency during early pregnancy. Misregulation of the progesterone production in Cyp11a1 transgenic mice during pregnancy resulted in aberrant implantation, anomalous placentation, and delayed parturition.
INTRODUCTION
Progesterone (P4) is a steroid hormone that supports pregnancy [1] . Progesterone prepares the uterine endometrium for embryo implantation during early pregnancy [2, 3] . It recruits and modulates uterine natural killer and dendritic cells to promote decidualization [4] [5] [6] . It also prevents uterine contraction to maintain pregnancy [7] [8] [9] [10] . Progesterone levels rise immediately after fertilization and remain high through gestation until several days before parturition [11, 12] . Therefore, the regulation of P4 secretion is essential for successful pregnancy. Progesterone deficiency is also associated with higher risk for premenopausal breast cancer [13] .
Progesterone is produced in ovarian luteal cells, which are differentiated from ovarian granulosa and theca cells [1, 14] . Luteinization involves the cessation of granulosa cell proliferation and increased progesterone secretion. Genes involved in steroidogenesis, such as luteinizing hormone/choriogonadotropin receptor (LHCGR), prolactin receptor (PRLR), steroidogenic acute regulatory protein (StAR), cytochrome P450, family11, subfamily A, polypeptide1 (CYP11A1), and hydroxy-delta-5-steroid dehydrogenase (HSD3B), are also upregulated after luteinization [1, 14] . In addition to functional changes, luteal cells have lower nucleus-to-cytoplasm ratios, while blood vessels are also growing during the formation of corpus luteum [14] .
P4 is synthesized via two catalytic steps using cholesterol as the precursor [1, 15] . The first step of P4 synthesis is catalyzed by the cytochrome P450 side chain cleavage enzyme P450scc (CYP11A1 [SCC), which converts cholesterol into pregnenolone (P5) on the matrix side of the inner mitochondrial membrane [16] . Thereafter, P5 serves as a substrate for HSD3B [17] .
CYP11A1 is essential for steroid biosynthesis, and therefore, it has been the focus of many studies [18, 19] . CYP11A1 polymorphism and overexpression have been associated with susceptibility to breast cancer and polycystic ovary syndrome, respectively [20] [21] [22] . CYP11A1 mutations in human patients cause adrenal and gonadal failure [23] but are compatible with term gestation [24] . In mice, Cyp11a1 knockout caused neonatal death due to deficiency in steroid production [25] , and fetal adrenal development was defective [26] . Despite these investigations of Cyp11a1 deficiency, the effects of Cyp11a1 overexpression have not been studied. To understand the phenotypes of Cyp11a1 overexpression, in this study we generated Cyp11a1 transgenic mice, which serve as a good model for detailed analysis. We found the major defect in these transgenic mice is pregnancy failure.
MATERIALS AND METHODS

Transgene Construction
The FLAG epitope tag was inserted into the Cyp11a1 gene at the C-terminal end of the coding region using a Red/ET recombination kit (Gene Bridges). This gene in a bacterial artificial chromosome (BAC clone RP23-159B15 obtained from BAC/PAC resources, Oakland Children's Hospital) was linearized by AatII at the 5 0 end and by SacII at the 3 0 end. The resulting 86-kb Cyp11a1 fragment contained a 53-kb upstream sequence, 12 kb of the Cyp11a1 gene, and a 21-kb 3 0 sequence (Fig. 1A ). This fragment was purified by pulsed field electrophoresis and gel elution before subsequent pronuclear injection for the generation of transgenic mice.
Ethics Statement
Mice were kept under specific-pathogen-free conditions in a 14L:10D cycle, following guidelines approved by the Academia Sinica Institutional Animal Care and Utilization Committee.
Generation of Cyp11a1 Transgenic Mice
The FLAG-tagged Cyp11a1 gene was inserted into the genome of C57BL/6 mouse background by pronuclear microinjection, and 9 of 25 founders transmitted the transgene to their offspring successfully. Genotyping was performed by PCR of genomic DNA under the following conditions: one cycle at 958C for 10 min, 30 cycles at 958C for 30 sec, 558C for 60 sec, and 728C for 90 sec, followed by one cycle at 728C for 5 min.
Determination of Estrous Cycles
Stages of the estrous cycle were determined by daily vaginal smears collected between 1500-1700 h. Proestrus was defined as nucleated epithelial cells with between no and a few leucocytes. At estrus, numerous keratinized cells with degenerate nuclei appeared. At metestrus, abundant infiltration of leukocytes was found; and at diestrus, leukocytes were mixed with nucleated epithelial cells.
Antibodies
Anti-CYP11A1 antibody, described previously [27] , was diluted 1:5000 and 1:500 for Western blotting and immunohistochemistry tests, respectively. Flag-M2 antibody (Sigma) was diluted 1:7500 for immunoblotting analysis or 1:200 for immunohistochemistry testing. Commercial antibodies used were: eomesodermin (EOMES; 1:500 dilution; product no. ab23345; Abcam, Inc.), progesterone receptor (PGR; 1:200 dilution; product no. A0098; DAKO).
Western Blotting
Total proteins were isolated from tissues and lysed in lysis buffer (100 mM potassium phosphate, pH7.8, 0.2% Triton X-100, 0.5 mM DTT, 0.2 mM PMSF) containing proteinase inhibitor cocktail (Roche). Equal amounts of total proteins were separated by SDS-PAGE, then transferred to Immobilon TM-P membrane (Millipore). Blots were incubated with primary antibody overnight at 48C or for 1 h at room temperature and then with horseradish peroxidaseconjugated secondary antibody for 1 h. Signals were detected by chemiluminescence assays.
Tissue Staining
Tissue sections were dewaxed and rehydrated in a series of alcohol to water steps. Slides were stained with hematoxylin for 30 secs and with eosin for 5 min.
For immunohistochemical staining, endogenous peroxidase activity of the tissue was blocked with 3% H 2 O 2 in methanol for 10 min followed by three water rinses for 5 min each. Antigen was retrieved in 0.1 mM citrate acid for 15 min at 958C-998C on a hot plate, followed by resting at room temperature for 30-60 min. Tissue sections were preincubated with 5% normal goat serum in 0.3% Triton X-100/phosphate-buffered saline (PBST) for 30 min, followed by incubation with primary antibodies at room temperature for 1 h or at 48C overnight, depending on the properties of the antibodies. After being washed with PBST, tissue sections were incubated with biotinylated secondary antibody (DAKO) for 30 min and washed with PBST three times for 5 min each, followed by color reaction in diaminobenzidine for 2 min. Slides were dehydrated and mounted in Permount. Signals were observed using an AxioImager Z1 microscope (Zeiss).
Steroid Measurements
Sera from adult mice were collected into serum tubes (Microtainer; BD) by submandibular bleeding. Samples were collected from pregnant mice between 0900 and 1000 h on gestational day (GDs) 1, 3, and 4 before being euthanized or between 1800 and 1900 h on other gestational stages. For nonpregnant mice, sera were collected from 1800-1900 h for the measurement of P4 and from 2100 to 2130 h for P5 measurement. Concentrations of P4, estradiol (E2), P5, and corticosterone (CORT) were measured using commercially available ELISA kits (from Cayman for P4 and CORT; from Alpco for P5; and from Calbiotech for E2).
Superovulation, Oocyte Quantitation and In Vitro Culture of Blastocysts
Four transgenic and three nontransgenic prepubescent female littermates (25-28 days, 12-16 g body weight) were first primed with intraperitoneal (ip) injection of equine chorionic gonadotropin ([eCG], 5 IU; Sigma) and 48 h later received a single ip injection of 5 IU human chorionic gonadotropin ([hCG] , Sigma) to induce ovulation. The cumulus-oocyte complexes were surgically harvested from the oviducts 22 h after hCG administration. The number of oocytes was counted after disassociation from surrounding cumulus cells by 0.3% hyaluronidase (Sigma). For in vitro culture, blastocysts were isolated from uteri and collected in M2 medium. Blastocysts were transferred to gelatin-coated tissue plates in Dulbecco modified Eagle medium supplemented with high glucose, sodium pyruvate, 15% FBS, 2 mM L-glutamine, 0.1 mM nonessential amino acids, 0.1 mM b-mercaptoethanol, and 1000 U of leukemia inhibitory factor/ml. The plates were incubated in 5% CO 2 at 378C for 72 h. After culturing for the indicated time, the hatched embryos were examined by light microscopy.
Decidual Staining and P4 Injection
Adult female mice were individually housed after copulation. On GD6, deciduas were stained after 0.1 ml of 1% Chicago Sky Blue 6B dye (Sigma) was injected into the tail vein of mice. One milligram of progesterone in sesame oil was injected ip daily from GD2 to GD4 for the examination of P4 supplementation.
Transmission Electron Microscopy
Tissues were sliced into small pieces, fixed for overnight incubation in 2.5% glutaraldehyde and 2% paraformaldehyde in 0.1 M sodium cacodylate (pH 7.0-7.4), at 48C, and then washed with 0.1 M sodium cacodylate, 0.1 M sucrose, and 0.05% CaCl 2 three times for 20 min each. Tissues were postfixed in 1% osmium tetroxide (OsO 4 ) solution in 0.1 M sodium cacodylate for 1 h and then washed with dH 2 O three times for 20 min each. The membrane structure was prestained with 2% uranyl acetate at 48C for 1 h, followed by three 30-min washes in dH 2 O. After serial dehydration by ethanol and gradual replacement with Spurr resin (no. 14300; EMS), tissues were embedded in pure Spurr resin containing dimethylaminoethanol catalyst. Ultrathin sections were stained with 8% uranyl acetate at room temperature for 5 min and Reynold lead citrate (Merck) at room temperature for 7 min before being examined with electron microscopy (G2 Spirit Twin model electron microscope; Tecnai; FEI Co.).
RNA Extraction, RT Reaction, and Real-Time PCR
Tissues were collected and lysed in TRIzol (Invitrogen Life Technologies) for RNA extraction. Total RNA (2 lg) was reverse transcribed using Maxima reverse transcriptase (Fermentas), followed by real-time PCR (LightCycler 480; Roche) according to the manufacturer's instruction. The SYBR Green detection system was used for the detection of signals shown in Figure 6A , and the TaqMan assay was used to produce the results shown in Figure 6 , B and C, and Supplemental Fig. S4 . Primer sequences are available in Supplemental Materials (available online at www.biolreprod.org). The levels of mRNAs were calibrated against those of Rplp0 (36B4, ribosomal large protein) or Rpl19 (ribosomal protein L19) when mRNAs were abundant (PCR cycle threshold [Ct] value ,23), or against those of TATA box binding protein (TBP) when mRNA levels were low (PCR Ct value .25). The relative quantities of transcripts were calculated by the 2 ÀDDCt method after efficiency correction. All the mRNAs were then normalized against the average of nontransgenic mRNAs on GD1 to obtain the relative message abundance and standard deviations.
Filipin Staining of Free Cholesterol
OCT-embedded tissues were frozen, sliced, rinsed with PBS three times, and then fixed with 4% paraformaldehyde for 30 min at room temperature. After tissues were rinsed three times in PBS, paraformaldehyde was quenched with 1.5 mg/ml glycine in PBS for 10 min at room temperature. Tissue sections were washed with PBS three times before being stained with 0.05 mg/ml filipin (Sigma) in PBS for 2 h at room temperature. Slides were covered with coverslips and mounted with 90% (v/v) glycerol in PBS.
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Ovarian P450scc Enzymatic Activity
Each whole ovary was collected from mice between 2130 and 2230 h at the indicated estrous stages, sliced with one cut, and then put directly into 24-well culture plates with 0.5 ml/well no-phenol red RPMI 1640 medium (Life Technologies). Activity of 3b-hydroxysteroid dehydrogenase was first blocked by 10 lM trilostane (Sigma) for 30 min and then incubated for a further 4 h with the addition of CYP11A1 substrate, 12.5 lM 20a-hydroxycholesterol (Sigma). Medium was collected, and amounts of P5 in the medium were measured. Ovarian P450scc enzymatic activity was determined as the secreted levels of P5 per total protein amounts.
Statistical Analyses
Data were analyzed by Student t-test and are shown as means 6 SEM. Graphs were prepared using Prism version 5.0 software (Graph Pad).
RESULTS
Generation of Cyp11a1 Transgenic Mice
To explore the consequence of Cyp11a1 overexpression in vivo, we generated Cyp11a1 transgenic mice by injecting the Cyp11a1 gene in a bacterial BAC. After pronuclear microinjection of the transgene, 25 Cyp11a1 transgenic founders were generated, and 9 successfully transmitted the transgene to their offspring. The exogenous CYP11A1 (P450scc [SCC]) could be distinguished from endogenous SCC by size because it carried a FLAG epitope tag. Transgenic founders Tg8 and Tg9 expressed higher levels of CYP11A1 and were characterized in more detail (Fig. 1B) . SCC was expressed mainly in adrenals and gonads of wild-type mice (Fig. 1C, upper panel) . The transgene was also expressed in the adrenals and gonads, as detected by the FLAG antibody (Fig. 1C) . Immunohistochemical analysis showed that the transgene was strongly expressed in the corpus luteum, theca, and interstitia of the ovary (Fig.  1D ) and the cortex of the adrenal (Fig. 1E ), identical to that of endogenous CYP11A1. It was also expressed at a very low level in granulosa cells in the preovulatory follicle in the same pattern as that of endogenous CYP11A1 ( Fig. 1D and Supplemental Fig. S1 ). Therefore, the transgene is expressed in the same cell types as endogenous Cyp11a1.
In order to examine whether the transgene has functional enzymatic activity, we mated Tg9 transgenic mice with Cyp11a1 knockout mice. Cyp11a1 knockout causes neonatal death and adrenal disorganization because of the lack of steroid production [28] . The presence of the transgene on a knockout background was confirmed by the presence of the FLAG-CYP11A1 (SCC-F) transgene and the absence of endogenous SCC in immunoblot analysis (Fig. 1F) . This mouse survived to adulthood with normal adrenal zonation (Fig. 1F ). These results demonstrate that the Cyp11a1 transgene has the full capacity to replace the endogenous gene with its normal adrenal function. P450scc activity in the Tg8 ovary was also higher than in the control ovary at metestrus stage of the estrus cycle (Supplemental Fig. S2A ), suggesting that the transgene is enzymatically active in the cycling ovary.
Estrous Cycle and Normal Capacity of Ovulation in Cyp11a1 Transgenic Mice
When breeding these mouse lines, we noticed that transgenic females failed to produce live pups, which would pass the transgene to the next generation by males. We examined their estrous cycles by daily vaginal smear analysis. They were grossly normal, but Tg8 and Tg9 ovaries spent less time at proestrus and more time at the stage going from proestrus to estrus, indicating that they had a tendency to enter estrus earlier than control littermates ( Fig. 2A) . Serum levels of P4 (Supplemental Fig. S2B ) and P5 (Supplemental Fig. S2C) were not different between control littermates and Tg8 females during estrous cycles. Therefore the increased P450scc activity in the transgenic mice did not seem to affect circulating pregnenolone and progesterone levels.
To investigate the competence of ovulation in transgenic females, we performed superovulation to calculate the numbers of ovulated oocytes. Tg8 females and control littermates produced similar numbers of eggs after superovulation (Fig.  2B) . By natural mating, Tg8 transgenic females produced normal numbers of fertilized eggs (Fig. 2C) and normal blastocysts that could develop into embryonic stem cell colonies in vitro (Fig. 2D) . Thus, Tg8 females can ovulate to produce eggs capable of further development.
Impaired Pregnancy in Cyp11a1 Transgenic Females
To further characterize the pregnancy problem in these transgenic females, pregnancy rates were examined. Pregnancy in a female is defined as the possession of fertilized eggs on GD1, blastocysts on GD4, embryos on GD6 and GD7, and fetuses near term (on GD19) after mating was ascertained by the presence of copulatory plugs. The average pregnancy rate was approximately 80% in nontransgenic mothers throughout the entire gestation period, whereas in Tg8 mothers it was 33% at postimplantation stage on GD6 and GD7 and was further diminished to 25% after placentation on GD9 (Fig. 3A) . The number of embryos carried in each Tg8 transgenic mother was normal but dropped after implantation on GD7 and GD9 (Fig.  3B) , and there was no live birth (Fig. 3C ). Tg8 and Tg9 males were fertile and sired the same number of live pups as nontransgenic mice (Fig. 3C) , confirming that the lack of live birth was due to defects in the transgenic mothers rather than transgenic embryos.
Because the pregnancy rate dropped during the implantation window, we examined this stage by the presence of decidua on GD6 (Fig. 3D) . Approximately 80% of wild-type females developed deciduas in their uteri 6 days after mating, yet only 30% Tg8 mothers developed deciduas (Fig. 3E) , indicating an implantation problem.
The pregnancy rate in transgenic mothers decreased further during the time of placenta formation on GD9, so the placentation process was examined. At this stage, the deciduas of nontransgenic mothers displayed the mesometrium and antimesometrium that were discernable by hematoxylin-eosin (H&E) staining, and an ectoplacental cone (EPC) containing IMPAIRED PREGNANCY IN Cyp11a1 TRANSGENIC MICE trophoblast giant cells (TGC) was formed in the mesometrial part (Fig. 3F) . Each decidua also contained an implanted embryo. The mesometrium and antimesometrium domains in the decidua of more than 50% of Tg8 females, however, could not be distinguished. The EPC and embryos were also missing in these deciduas, indicating a placentation problem.
We examined these deciduas for expression of EOMES, a marker for early placentation [29] . EOMES was found in the mesometrium of nontransgenic decidua on GD9; however, it was missing in the Tg8 decidua. Another transcription factor, PGR, was expressed in the mesometrium part of the normal decidua, but in Tg8 the expression was expanded to the entire decidua (Fig. 3F) . Thus, decidual polarity was lost in Tg8 females during pregnancy.
Defects in Transgenic Corpora Lutea During Early Pregnancy
We examined the ovarian sections and found that the cytoplasm of Tg8 luteal cells appeared more translucent and had accumulations of numerous lipid droplets, detected by transmission electron microscopy (Fig. 4A) . These lipid droplets probably contained mainly cholesterol ester, as it is the major component of lipid droplets in most steroidogenic cells. Furthermore, the amount of free-form cholesterol in transgenic luteal cells was reduced as shown by filipin staining (Supplemental Fig. S3A ). The accumulation of lipid droplets, however, was partially relieved on GD9 (Supplemental Fig.  S3B) .
We noticed the number of mitochondria in normal luteal cells was much higher than in granulosa cells on GD4, whereas the total numbers of mitochondria in the transgenic luteal cells remained low, similar to numbers seen in granulosa cells (Fig.  4B ). In addition, normal mitochondria were spherical in luteal cells but were elongated in granulosa cells (Fig. 4C) . The mitochondria in transgenic luteal cells remained elongated on GD4 just like those in granulosa cells (Fig. 4D) . Thus Tg8 luteal cells contain mitochondria resembling the mitochondria of granulosa cells in shape and number, indicating a delayed luteal cell differentiation from granulosa cells.
Misregulated Progesterone in Cyp11a1 Transgenic Mothers During Pregnancy
Progesterone is a major steroid that supports pregnancy; therefore, we measured serum P4 levels in these mice. P4 levels in nontransgenic mothers increased after fertilization and reached the highest level on GD8 (Fig. 5A) . Tg8 P4 levels were initially low and increased more slowly but accumulated later during gestation and reached levels similar to those of nontransgenic mothers at approximately GD9.
When nontransgenic mothers prepared to deliver their pups, their P4 levels were reduced to the basal levels at term (Fig.  5B) . However, the P4 levels of Tg8 Cyp11a1 transgenic mothers declined more slowly, and parturition was delayed for 3 days (Fig. 5B ). This delayed labor may be the cause of pup death upon delivery.
In contrast to P4, the circulating levels of P5, CORT, and E2 in transgenic mothers were all normal during early pregnancy (Supplemental Fig. S2, D-F) . Pituitary Prl, Gnrhr, Fsh, and Lhb mRNAs were also unchanged (Supplemental Fig.  S4 ).Therefore, misregulation of P4 in transgenic mothers is a prominent defect during pregnancy.
P4 Supplementation Rescued Implantation Rates but Not Foaming Appearance in Transgenic Luteal Cells on GD4
To further confirm the aberrant implantation resulting from P4 insufficiency, we injected P4 daily after the formation of copulatory plugs; this resulted in the restoration of circulating P4 levels in transgenic mothers (Fig. 5C ). More deciduas were formed, and the implantation rate was also rescued (Fig. 5D) . However, transgenic luteal cells still appeared foamy on GD4 (Fig. 5E) . These results show that the anomalous implantation in these transgenic mothers is the result of insufficient P4 production from defective transgenic corpora lutea.
Steroidogenesis and Cholesterol Availability Are Disrupted in Transgenic Ovaries During Early Pregnancy
To investigate the defective development of transgenic luteal cells, we examined genes responsible for steroidogenesis and cholesterol availability by quantitative (Q)-RT-PCR. Genes required for P4 production in the corpus luteum, such as StAR, Cyp11a1, Hsd3b1, and luteinizing hormone/choriogonadotropin receptor (Lhcgr), were increased during normal pregnancy from GD1 to GD4; however, except for Cyp11a1, which was always high because of the presence of the Cyp11a1 transgene, they remained low in transgenic Tg8 ovaries on GD4 (Fig. 6A). Akr1c18 (20a-Hsd) , the gene responsible for progesterone degradation, was also not increased (Fig. 6A) , suggesting that progesterone insufficiency is probably not caused by increased degradation.
The genes for cholesterol availability, Scarb1 (HDL receptor), Ldlr (LDL receptor), Lipe (hormone-sensitive lipase), Hmgcr, and Insig1 (regulators of de novo synthesized cholesterol), were also diminished in transgenic Tg8 ovaries (Fig. 6B) . Most of the genes required for P4 production were restored except for Scarb1 and Hmgcr on GD8 (Fig. 6C) . These gene expression data are consistent with the finding that P4 secretion returned to normal on GD9 (Fig. 5A) . These results suggest that impaired steroidogenesis and cholesterol use led to P4 insufficiency in transgenic mothers during early pregnancy.
DISCUSSION
In this study, we generated Cyp11a1 transgenic mice and found female transgenic mice had pregnancy failure resulting from delayed luteal cell differentiation and insufficient P4 secretion during early pregnancy. We showed that the pregnancy failure was caused by defects in implantation, placentation, and parturition. This study revealed that overexpression of Cyp11a1 could lead to delays in luteal cell differentiation and misregulation of steroid secretion, resulting in pregnancy defect.
Transgenic Cyp11a1 Recapitulates Endogenous Gene Expression
In this study, we generated transgenic mice expressing FLAG-CYP11A1, using a BAC construct. This method ensured expression of the transgene in all CYP11A1-expressing cells such as adrenocortical, ovarian luteal, thecal, and stromal interstitial cells. This is probably because we included a large portion of the region in the transgene, including 53 kb of the 5 0 -flanking sequence and 21 kb of the 3 0 -flanking sequence, which would ensure inclusion of all the regulatory elements. The transgene appears to be enzymatically active as shown by the enzymatic activity assay and by its ability to rescue the defect of Cyp11a1 null mice. During proestrus, estrus, and diestrus of the estrous cycle, transgenic P450scc activity did not seem to elevate much in the ovary probably because P450scc was at the low basal level. It was increased in Tg8 ovary during the metestrus, the stage when corpora lutea start to form. The increased enzymatic activity in the transgenic mice, however, does not seem to cause major P4 imbalance in cycling females and ovulation appears to be normal. However, it affects pregnancy, as we detected pregnancy failure in the transgenic mice. 
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Inadequate P4 in Cyp11a1 Transgenic Mothers Fails To Sustain Embryonic Development After Implantation
Progesterone is indispensable to implantation, such as in establishment of uterine receptivity for conceptus attachment and decidualization of uterine stroma cells [3] . Here we found that inadequate P4 during the implantation window caused embryo loss in Cyp11a1 transgenic mothers, and P4 injection rescued the defect.
Apart from implantation and placentation defects, preimplantation embryos appeared normal because, in transgenic oviducts, comparable quantities of zygotes were present, and these blastocysts had normal competence to expand into embryonic stem cell colonies. These results indicate that delayed increase of P4 in transgenic mothers did not retard embryonic development before implantation but that P4 is essential for subsequent events during pregnancy.
Loss of Mesometrium-to-Anti-Mesometrium Polarity in Transgenic Deciduas During Placentation GD9 transgenic uteri had placentation defects. Approximately half of the EPC disappeared, and no embryo existed in the cavities of these transgenic deciduas. These findings suggest that insufficient P4 in transgenic mothers on GD8 could not support EPC formation.
The EPC is formed between the fetal chorion and maternal mesometrium during placentation [30] . We found that EOMES expression was restricted in the mesometrial decidual cells in wild-type mice and that this expression was lost in transgenic mothers. EOMES is essential for trophoblast development [29, 31] and the maturation of uterine natural killer cells at decidua basalis during GD6-GD10 [32] . The loss of EOMES expression in transgenic mesometrial deciduas may lead to placentation defects. Similarly, nuclear PGR was expressed in the mesometrial side of control deciduas, whereas in transgenic deciduas, PGR was found in both the mesometrium and antimesometrium. These results indicate that placentation requires polarized decidua.
We found that 50% of implanted deciduas in transgenic uteri had no typical EPC-containing TGC and showed only invasive decidual cells in the cavity. There is a transient peak of steroidogenesis in TGC during placentation [33, 34] . Moreover, transgenic blastocysts had competence for the inner cell mass expansion in vitro, suggesting that there is no autonomous defects in trophectoderm-derived TGC. These findings imply that decidual polarity is established during implantation and that loss of polarity of decidual cells may disrupt placentation, such as the formation of EPC. These implantation and placentation defects observed in transgenic uteri and the resultant embryo loss were caused by P4 insufficiency from GD3 to GD8. Reduced mRNA levels involved in P4 synthesis/degradation and cholesterol availability, respectively, as determined by Q-RT-PCR. d1, GD1; d4, GD4. Eight ovarian RNA samples were used in each genotype, except for the detection of Akr1c18, for which four RNA samples were used for each genotype. C) Partial recovery of genes in steroidogenesis and cholesterol availability in transgenic ovaries on GD8. Genes related to P4 synthesis and cholesterol availability were examined by real-time Q-RT-PCR. Data are means 6 SEM. #P , 0.001; *P , 0.05. AU, arbitrary unit.
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Cyp11a1 Transgenic Mice Are Impaired in Luteal Differentiation During Early Pregnancy
In addition to implantation and placentation defects, Cyp11a1 transgenic females were impaired in their ovarian functions. The cytoplasm of transgenic luteal cells was translucent on GD4, and these cells were defective in steroidogenesis and cholesterol availability. These defects were not rescued by P4 injection. Although transgenic luteal cells were defective, their cell fate was not changed as these cells were luteinized, and steroidogenic genes such as Cyp11a1 and Hsd3b1 were expressed. Instead, the defect appears to be in luteal cell maturation. During normal pregnancy, luteal cell maturation was manifested by increased expression of genes for steroidogenesis and cholesterol availability. This was accompanied by an increase in mitochondrial numbers and change of mitochondria into spherical shape with tubularvesicular cristae. This maturation process was delayed in transgenic ovaries. Transgenic luteal cells still retained mitochondria with shape and numbers like those in granulosa cells, and the expression of genes for steroidogenesis and cholesterol availability was not increased with time. These defects parallel the apparent accumulation of lipid droplets in transgenic luteal cells. Thus, Cyp11a1 transgenic mice have multiple defects during pregnancy, including a defect in luteal cell maturation.
In this report, we have characterized the steps of luteal development during early pregnancy. These steps include the rise of steroidogenic gene expression and the increase of cholesterol mobilization, which are accompanied by an increase in P4 secretion. Not only is gene expression changed during this process, mitochondria within the cells also undergo prominent changes. After luteinization, mitochondria increase in numbers and change into the spherical form as opposed to the elongated form observed in the granulosa cells. Because mitochondria are the major sites of steroid hormone synthesis, the increase in mitochondrial numbers and the changes in mitochondrial morphology indicate that this organelle is prepared for more P4 production during early pregnancy. Insufficient mitochondrial transformation and inadequate steroidogenic gene stimulation in the Cyp11a1 transgenic ovary led to progesterone deficiency and pregnancy failure.
Misregulation of P4 in Transgenic Mothers During Pregnancy and Causes of Recurrent Pregnancy Loss and Delayed Parturition
Cyp11a1 transgenic mothers did not secrete enough P4 at peri-implantation and were delayed in P4 withdrawal near term. Parturition time is governed by luteolysis in rodents and functional P4 withdrawal in humans [35, 36] . Here, transgenic luteal cells initiated differentiation normally but were delayed in maturation during early pregnancy. Some embryos from transgenic mothers still survived at embryonic day 18.5 but died by natural delivery. It will be interesting to determine whether luteolytic factors such as PGF2a delay the onset of luteolysis or whether other unknown luteotropic factors prolong pregnancy.
Recurrent pregnancy loss (RPL) is a common disease caused by inadequate P4 secretion leading to syndromes such as luteal phase deficiency, hyperprolactinemia, and polycystic ovary syndrome [37] . However, the causative factors attributed to unexplained RPL are still under investigation. Pregnancy is confirmed and judged by hCG test and ultrasonography detection in clinical examinations of natural conception [38] . The successful implantation of human blastocysts occurs between 8 and 10 days after ovulation, whereas 3-day implantation delay caused more than 50% embryo loss [38] . In this study, we observed that progesterone insufficiency led to a large proportion of impaired implantation in Cyp11a1 transgenic mothers; nevertheless, these females had normal folliculogenesis and ovulation ability. In Cyp11a1 transgenic mothers, the defective differentiation of corpora lutea resulted in P4 insufficiency, decreased implantation rates, and aberrant placentation. It will be interesting to find out whether P4 insufficiency caused by CYP11A1 overexpression is also a factor for unexplained RPL patients. Monitoring of the P4 levels between natural fertilization and the implantation window in routine examinations of pregnancy may be recommended as a factor contributing to unexplained RPL or infertility.
